Full text is available at the source.
Abstract
A brain-penetrant GLP-1 receptor agonist may alter metabolic coupling between astrocytes and neurons.
- Metabolic dysfunction is a significant characteristic of Alzheimer's disease.
- The GLP-1 receptor agonist influences how astrocytes supply energy to neurons.
- Lactate, a byproduct of glucose metabolism, plays a role in modifying histones, which are proteins that help package DNA.
- This modification connects astrocytic energy production to the regulation of fats in neurons.
- The findings suggest that targeting metabolite signaling could be a potential strategy for treating neurodegeneration.
Simplified